@daveaspreyofficial's low testosterone signs, fact-checked

What did @daveaspreyofficial actually say?

Asprey claims there are three signs of "alarmingly low" testosterone that apply to both men and women: low sex drive, absent morning erections in men, and reduced motivation or depression. He then says average testosterone levels are "50% below where they were 25 years ago," sets a target range of 700-1000 for men "no matter your age," and recommends the Bulletproof diet, vitamin D (targeting 70-90 ng/mL blood levels), cutting seed oils, and avoiding endocrine disruptors. He closes with a blanket recommendation to start testosterone replacement therapy if lifestyle changes do not work, calling TRT "part of a normal anti-aging strategy" for both men and women.

That is a lot of claims packed into a short video, and they are not all created equal. Some are grounded in real physiology. Others are stretched well past what the evidence supports.

Does the science back this up?

Partially. The symptoms Asprey lists are real symptoms of hypogonadism, but the population-level testosterone decline claim is overstated, and his single target range for all men regardless of age ignores how reference intervals actually work.

The symptoms, low libido, reduced morning erections, and low motivation, are indeed associated with low testosterone in men. A 2018 study by Rastrelli and Maggi in Best Practice and Research: Clinical Endocrinology and Metabolism confirmed morning erection frequency correlates meaningfully with testosterone status. The link between testosterone and depressive symptoms is real but bidirectional and often confounded.

On the population decline: a frequently cited paper by Travison et al. (2007, Journal of Clinical Endocrinology and Metabolism) did find declining testosterone levels across generations in a Massachusetts cohort, but the magnitude was roughly 1% per year across decades, not the clean "50% drop in 25 years" figure Asprey states. That specific statistic appears to conflate multiple datasets and is not directly supported by a single peer-reviewed source.

The vitamin D and testosterone link has modest support. A randomized controlled trial by Pilz et al. (2011, Hormone and Metabolic Research) found supplementing vitamin D in deficient men raised testosterone modestly. But the effect size is small, and it does not justify Asprey's specific blood level targets of 70-90 ng/mL, which exceed most clinical guidelines.

What did they get wrong (or right)?

The blanket statement that men should have testosterone "between 700 and 1000 no matter your age" is a meaningful error. Reference ranges are age-adjusted for a reason. The Endocrine Society's clinical guidelines acknowledge that levels naturally decline with age and that symptoms, not a single number, should guide treatment decisions.

The BPA-on-receipts warning is actually reasonable. Thermal paper receipts are a documented source of BPA skin absorption (Hormann et al., 2014, PLOS ONE), and BPA is a confirmed endocrine disruptor. Credit where it is due.

The recommendation that women should start TRT if lifestyle changes do not work is the most medically aggressive claim in the video. Testosterone therapy in women is approved only for hypoactive sexual desire disorder in postmenopausal women in most countries, and only at low doses. Recommending it broadly as an "anti-aging strategy" for women, without discussing risks including androgenic side effects and limited long-term safety data, is irresponsible at 291,000 views.

The Bulletproof diet and seed oil advice has no direct clinical trial evidence linking it to testosterone restoration. Seed oil avoidance is a recurring claim in biohacking content that has not been validated in controlled testosterone studies.

What should you actually know?

If you recognize Asprey's described symptoms in yourself, getting tested is reasonable advice. The problem is what happens after that recommendation in this video.

Testosterone levels should be interpreted in context: time of day matters (levels peak in the morning), lab method matters, and symptoms must be weighed alongside numbers. The Endocrine Society recommends two separate morning measurements before diagnosing hypogonadism. A single test prompted by a TikTok video is not a diagnosis.

For women, testosterone reference ranges are narrower, less standardized, and more cycle-dependent than for men. Asprey is right that timing matters for women's testing, but the leap to TRT as a general recommendation glosses over real risks, including acne, hair loss, clitoral enlargement, and unknown long-term cardiovascular effects.

Telehealth platforms offering hormone testing and treatment should be working from validated symptom questionnaires, two confirmed low-morning blood draws, and a full clinical picture. "I watched a video and I feel unmotivated" is a starting point for a conversation, not a prescription rationale. If your levels are genuinely low and symptoms are affecting your life, talk to a physician who specializes in endocrinology or men's or women's health, not just a "functional doctor" who may be operating outside evidence-based clinical guidelines.